Over the last 18 months, the company has more than quadrupled the size of its cannabis store network.
The company also introduced two new cultivars during the quarter
Clinical psychedelic sector value anticipated to ascend significantly into 2028
The drop was due to a shift in Numinus Bioscience operations
Friday the 1st sees a 19% increase in pot-derived revenue from 2021
Kiaro's eCommerce revenue growth went up 26% in the last quarter
Revenues increased as a result of the company completing the construction of its Kelowna-based production facility
Company growth within Colombia and Europe responsible for financial success this quarter
The company posted a net loss of $5.8 million for Q1 2022, compared to a loss of $7 million during the same period last year
The cannabis retailer expanded its store portfolio from six to 28 corporate stores by the end of January
The company owns the brands Color Cannabis, Saturday Cannabis and Royal City Cannabis Co.
Cannabis revenue of $66 million during the fourth quarter represented a decline of 35 per cent
The launch of new products such as Cherry Mints, Maple Kush, pre-rolls boosted revenue this quarter
While revenue increased, Ayurcann reported gross margins of $580,000 in the first quarter, a 68 per cent decline from $1.8 million during Q1 2021
Rubicon’s national market share of premium flower and pre-rolls dipped to 7.1 per cent during the first quarter from 7.6 per cent during Q4 2021
Edible product sales represent 95% of net revenue in Q1 2022
Trees posted $1.7 million in revenue during the first quarter compared to $0.5 million in Q1 2021, representing an increase of 225 per cent
VIVO continues to pursue its international expansion strategy, which now represents more than 50 per cent of its cannabis revenue
The American company has recently shifted its strategy to incubate and spin out cannabis-related companies
Sundial's EBITDA plummeted to a $0.7 million loss during Q1 2022 after $18.4 million during the previous quarter
Q1 revenue was comprised of approximately 61 per cent in cannabis 2.0 product sales
Supply chain issues, project delays and seasonal weakness contributed to decreased revenue during the first quarter
The company also reported a 14 per cent decrease in revenue
The firm had an adjusted EBITDA of US$105.5 million, up 4.5 per cent from US$100.9 million during the fourth quarter of 2021
Its Valley, Anandia and Whisler Alpha Lake are expected to be closed by the fourth quarter
Nova’s sales growth resulted from new retail stores, transition to Value Buds low-cost model
Last March, the company reported a record 2021 revenue of US1.2 billion.
Adjusted EBITDA went to a negative $9.3 million from a positive $7.7 million in the last year
The company currently has 13 subsidiaries in 10 different countries
The company reported around $26.6M in losses this year
Sundials's EBITDA increased to $18.4 million during the fourth quarter, up 75 per cent from the previous quarter
Edible product sales represent 87% of net revenue in Q4 2021
Decibel marked its sixth consecutive quarter of positive EBITDA, reporting $1.5 million during the fourth quarter
Numinus' gross margin improved to 29.1 per cent during Q2 2022 following acquisitions of Mindspace Psychology Services Inc. and the Neurology Centre of Toronto
Following acquisitions and business transition, cannabis producer expects continued growth during 2022
The company says it has a 20% market share in Germany with its whole flower, extracts and Dronabinol products
The Canadian company sold a record of $5.18 million in cannabis products last December
The firm says it's reformulated its concentrate lines to meet client expectations related to terpenes
The firm is forecasting 2022 revenue of at least US$1.3B


































